Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-04-08 Sale | 2021-04-09 5:23 pm | Trillium Therapeutics Inc. | TRIL | Petrova Penka Chief Development Officer | 5,312 | $11.09 | $58,910 | 133,440 (Direct) | View |
| 2021-03-10 Sale | 2021-03-12 4:40 pm | Trillium Therapeutics Inc. | TRIL | Petrova Penka Chief Development Officer | 5,312 | $11.08 | $58,857 | 138,752 (Direct) | View |
| 2021-02-08 Sale | 2021-02-10 7:18 pm | Trillium Therapeutics Inc. | TRIL | Petrova Penka Chief Development Officer | 5,820 | $12.78 | $74,397 | 148,638 (Direct) | View |
| 2021-01-11 Sale | 2021-01-13 4:11 pm | Trillium Therapeutics Inc. | TRIL | Petrova Penka Chief Development Officer | 508 | $15.21 | $7,725 | 5,082 (Direct) | View |
| 2021-01-08 Sale | 2021-01-12 4:10 pm | Trillium Therapeutics Inc. | TRIL | Petrova Penka Chief Development Officer | 2,604 | $15.5 | $40,365 | 57,292 (Direct) | View |
| 2021-01-07 Sale | 2021-01-11 4:19 pm | Trillium Therapeutics Inc. | TRIL | Petrova Penka Chief Development Officer | 2,708 | $14.71 | $39,843 | 92,084 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-11-17 Disposition | 2021-11-19 1:24 pm | N/A 2025-11-19 | Trillium Therapeutics Inc. | TRIL | Petrova Penka Chief Development Officer | 316,822 | $0 | 0 (Direct) | View |
| 2021-04-08 Exercise | 2021-04-09 5:23 pm | N/A 2029-11-07 | Trillium Therapeutics Inc. | TRIL | Petrova Penka Chief Development Officer | 5,312 | $0 | 133,440 (Direct) | View |
| 2021-04-08 Exercise | 2021-04-09 5:23 pm | N/A N/A | Trillium Therapeutics Inc. | TRIL | Petrova Penka Chief Development Officer | 2,708 | $0.3022 | 133,440 (Direct) | View |
| 2021-04-08 Exercise | 2021-04-09 5:23 pm | N/A N/A | Trillium Therapeutics Inc. | TRIL | Petrova Penka Chief Development Officer | 2,604 | $3.3638 | 133,440 (Direct) | View |
| 2021-03-10 Exercise | 2021-03-12 4:40 pm | N/A 2029-11-07 | Trillium Therapeutics Inc. | TRIL | Petrova Penka Chief Development Officer | 5,312 | $0 | 138,752 (Direct) | View |
| 2021-03-10 Exercise | 2021-03-12 4:40 pm | N/A N/A | Trillium Therapeutics Inc. | TRIL | Petrova Penka Chief Development Officer | 2,604 | $3.3524 | 138,752 (Direct) | View |
| 2021-03-10 Exercise | 2021-03-12 4:40 pm | N/A N/A | Trillium Therapeutics Inc. | TRIL | Petrova Penka Chief Development Officer | 2,708 | $0.3012 | 138,752 (Direct) | View |
| 2021-02-08 Exercise | 2021-02-10 7:18 pm | N/A 2029-11-07 | Trillium Therapeutics Inc. | TRIL | Petrova Penka Chief Development Officer | 5,820 | $0 | 148,638 (Direct) | View |
| 2021-02-08 Exercise | 2021-02-10 7:18 pm | N/A N/A | Trillium Therapeutics Inc. | TRIL | Petrova Penka Chief Development Officer | 2,708 | $0.2977 | 148,638 (Direct) | View |
| 2021-02-08 Exercise | 2021-02-10 7:18 pm | N/A N/A | Trillium Therapeutics Inc. | TRIL | Petrova Penka Chief Development Officer | 2,604 | $3.3137 | 148,638 (Direct) | View |
| 2021-02-09 Exercise | 2021-02-10 7:18 pm | N/A N/A | Trillium Therapeutics Inc. | TRIL | Petrova Penka Chief Development Officer | 508 | $9.6213 | 148,638 (Direct) | View |
| 2021-01-11 Exercise | 2021-01-13 4:11 pm | N/A 2027-11-09 | Trillium Therapeutics Inc. | TRIL | Petrova Penka Chief Development Officer | 508 | $0 | 5,082 (Direct) | View |
| 2021-01-11 Exercise | 2021-01-13 4:11 pm | N/A N/A | Trillium Therapeutics Inc. | TRIL | Petrova Penka Chief Development Officer | 508 | $9.5671 | 5,082 (Direct) | View |
| 2021-01-08 Exercise | 2021-01-12 4:10 pm | N/A 2028-11-08 | Trillium Therapeutics Inc. | TRIL | Petrova Penka Chief Development Officer | 2,604 | $0 | 57,292 (Direct) | View |
| 2021-01-08 Exercise | 2021-01-12 4:10 pm | N/A N/A | Trillium Therapeutics Inc. | TRIL | Petrova Penka Chief Development Officer | 2,604 | $3.331 | 57,292 (Direct) | View |
| 2021-01-07 Exercise | 2021-01-11 4:19 pm | N/A 2029-11-07 | Trillium Therapeutics Inc. | TRIL | Petrova Penka Chief Development Officer | 2,708 | $0 | 92,084 (Direct) | View |
| 2021-01-07 Exercise | 2021-01-11 4:19 pm | N/A N/A | Trillium Therapeutics Inc. | TRIL | Petrova Penka Chief Development Officer | 2,708 | $0.2987 | 92,084 (Direct) | View |
Ownership | 2021-01-04 8:12 pm | N/A 2030-12-23 | Trillium Therapeutics Inc. | TRIL | Petrova Penka Chief Development Officer | 0 | $0 | 339,086 (Direct) | View |